Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Park Ha Biological Technology ( (BYAH) ) has issued an announcement.
At its Extraordinary General Meeting held on December 26, 2025, Park Ha Biological Technology Co., Ltd. secured strong shareholder approval for a significant expansion of its authorized share capital to US$3 million, now divided into 150 billion ordinary shares split between 120 billion Class A shares and 30 billion Class B shares, reinforcing its dual‑class structure and providing substantial headroom for future equity issuance. Shareholders also backed the adoption of a new amended and restated memorandum and articles of association to reflect the enlarged capital base and overwhelmingly authorized the board to implement a major share consolidation in a ratio ranging from 1‑for‑5 to up to 1‑for‑250 within one year of the November 21, 2025 record date, a move that positions the company with greater flexibility to manage its capital structure, address share price and liquidity considerations, and potentially support future strategic or financing initiatives.
More about Park Ha Biological Technology
Park Ha Biological Technology Co., Ltd. is a Cayman Islands–incorporated company headquartered in Wuxi, Jiangsu Province, China, and operates in the life sciences and biological technology sector. The company has a dual‑class share structure comprising Class A ordinary shares with one vote per share and Class B ordinary shares with 20 votes per share, reflecting a governance model that concentrates voting power with key insiders.
Average Trading Volume: 273,675
Technical Sentiment Signal: Strong Sell
Current Market Cap: $6.2M
For detailed information about BYAH stock, go to TipRanks’ Stock Analysis page.